Details

---

• Active Ingredient: Betahistine Dihydrochloride 24mg

• Manufacturer: Mylan Laboratories SAS, France

• Marketing Authorization Holder: Abbott Laboratories (M) Sdn. Bhd., Malaysia

• Product Registration Number (MAL): MAL07061394ACZ

Indications

Betaserc is indicated for the symptomatic treatment of:

• Ménière’s disease, characterized by the triad of vertigo, tinnitus, and hearing loss.

• Vestibular vertigo, including conditions like benign paroxysmal positional vertigo (BPPV).

Instructions for Use

• Dosage: 1 tablet (24mg) taken twice daily.

• Administration: Swallow the tablet whole with water; do not chew or crush.

• With or Without Food: It is recommended to take Betaserc with food to minimize potential gastrointestinal discomfort.

• Consistency: Take the medication at the same times each day to help remember.

• Monitoring: Regular follow-up with a healthcare provider is advised to assess the effectiveness and adjust dosage if necessary.